ClinicalTrials.Veeva
Menu

Find clinical trials for Alzheimer's Disease in Hanyang, Seoul

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Cognitive Dysfunction
Dementia
Mental Disorders
Neurodegenerative Diseases
Brain Diseases
Nervous System Diseases

Alzheimer's Disease trials near Hanyang, Seoul, KOR:

Pilot Clinical Trial to Assess the Safety of NMS-01 in Patients With Mild to Moderate Alzheimer's Disease (NMSBBBOYUSH01)

efficacy of the Focused ultrasound stimulator system (NMS-01) for transient Blood-Brain Barrier (BBB) opening in patients with mild to moderate Alzheimer's...

Enrolling
Alzheimer's Disease
Blood Brain Barrier
Device: NMS-01
Neumous Inc.

Seoul, Seodaemun, South Korea

To evaluate the safety and efficacy of PM012 tablets for Alzheimer's disease, dose-finding study will be performed on phase 2b, and...

Enrolling
Mild Alzheimer Disease
Drug: Donepezil
Drug: PM012 Placebo

Phase 2, Phase 3

Mediforum

Seoul, Seongdon-gu, Korea, Republic of

This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in p...

Active, not recruiting
Alzheimer's Disease
Biological: VHB937
Other: Placebo

Phase 2

Novartis
Novartis

Seoul, South Korea and 72 other locations

The goal of this clinical trial is to evaluate safety and potential therapeutic effect of intraveneously administered CB-AC-02 in patients with Alzheimer's...

Active, not recruiting
Alzheimer's Disease
Biological: Placebo
Biological: CB-AC-02

Phase 1, Phase 2

CHA Biotech

Seongnam-si, Gyeonggi-do, Korea, Republic of

of KDS2010 in patients with Mild Cognitive Impairment (MCI) due to Alzheimer's disease (AD) and mild dementia due to Alzheimer's...

Enrolling
Alzheimer's Disease
Mild Cognitive Impairment (MCI)
Drug: KDS2010
Drug: Placebo

Phase 2

NeuroBiogen Co., Ltd

Seoul, Seoul, South Korea and 7 other locations

The study medicine GSK4527226 is being studied in participants with Alzheimer's Disease (AD) in study 219867 (the parent study, NCT...

Enrolling
Alzheimer's Disease
Drug: GSK4527226

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Junggu, South Korea and 32 other locations

This 52-week, open-label extension study is to evaluate the long-term safety and tolerability of ACP-204 in subjects with ADP.

Invitation-only
Alzheimer's Disease Psychosis
Drug: ACP-204

Phase 3

Acadia Pharmaceuticals
Acadia Pharmaceuticals

Seoul, South Korea and 76 other locations

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease...

Enrolling
Alzheimer's Disease
Other: Placebo
Drug: KarXT

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Seoul, Seoul-teukbyeolsi [Seoul], South Korea and 117 other locations

This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: AR1001

Phase 3

AriBio

Seoul, South Korea and 199 other locations

This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies...

Enrolling
Alzheimer's Disease Psychosis
Drug: Placebo
Drug: ACP-204

Phase 2, Phase 3

Acadia Pharmaceuticals
Acadia Pharmaceuticals

Seoul, South Korea and 154 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems